Quantum-Si
Press Releases

Date

Title

May 13, 2026

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 7, 2026

Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones

May 1, 2026

Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

April 28, 2026

Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments

April 16, 2026

Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026

April 15, 2026

Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting

April 14, 2026

Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies

April 10, 2026

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 8, 2026

Quantum-Si Announces First Customer Samples Tested on the Proteus™ Prototype System

April 6, 2026

Quantum-Si Announces the Start of the Proteus™ Roadshow

March 13, 2026

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 3, 2026

Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results

February 13, 2026

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 10, 2026

Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

February 5, 2026

Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection

December 22, 2025

Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements

December 15, 2025

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 20, 2025

Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day

November 19, 2025

Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company’s Industry Leading Technology Pipeline at Investor & Analyst Day

November 5, 2025

Quantum-Si Reports Third Quarter 2025 Financial Results

October 20, 2025

Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

October 13, 2025

Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025

September 23, 2025

Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025

September 15, 2025

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 8, 2025

Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing

August 19, 2025

Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

August 13, 2025

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 8, 2025

Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit

August 5, 2025

Quantum-Si Reports Second Quarter 2025 Financial Results

July 21, 2025

Quantum-Si to Participate in the Canaccord Genuity 45th Annual Growth Conference

July 14, 2025

Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025

July 3, 2025

Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock

June 24, 2025

Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives

June 19, 2025

Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization

June 17, 2025

Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston

June 13, 2025

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 10, 2025

Quantum-Si’s Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay

May 15, 2025

Quantum-Si Reports First Quarter 2025 Financial Results

May 13, 2025

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 12, 2025

Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si’s Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15

April 24, 2025

Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025

March 26, 2025

Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™

March 20, 2025

Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research

March 13, 2025

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 3, 2025

Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results

February 18, 2025

Quantum-Si’s Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025

February 13, 2025

Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025

February 12, 2025

Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

February 11, 2025

Preprint from Northwestern University Highlights Complementary Proteomic Analysis of Interleukin-6 Using Next-Generation Protein Sequencing™ and Mass Spectrometry

February 4, 2025

Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies

January 28, 2025

Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument

January 20, 2025

Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK

January 17, 2025

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 13, 2025

Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics

January 8, 2025

Quantum-Si’s New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics

January 3, 2025

Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock

December 20, 2024

Quantum-Si’s New Preprint Showcases Advances in Protein Variant Detection using ProteoVue™ Software with Next-Generation Protein Sequencing™

December 18, 2024

Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

December 12, 2024

Quantum-Si Expands International Distribution Network

December 4, 2024

Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™

December 3, 2024

Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening

November 21, 2024

Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event

November 20, 2024

Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology

November 20, 2024

Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA

November 20, 2024

Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform

November 20, 2024

Quantum-Si and Planet Innovation to Partner on Proteus™

November 18, 2024

Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 13, 2024

Quantum-Si Honored with Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™

November 12, 2024

Quantum-Si Reports Third Quarter 2024 Financial Results

November 7, 2024

University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Si’s Next-Gen Protein Sequencer™ Platinum®

November 5, 2024

Quantum-Si to Participate in Upcoming Investment Conferences

October 31, 2024

Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024

October 30, 2024

Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting

October 23, 2024

Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

October 17, 2024

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 10, 2024

Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024

September 24, 2024

Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing

September 19, 2024

Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024

September 4, 2024

Liberate Bio Integrates Quantum-Si’s Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development

August 27, 2024

Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider

August 26, 2024

Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

August 7, 2024

Quantum-Si Reports Second Quarter 2024 Financial Results

July 30, 2024

Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference

July 17, 2024

Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024

June 10, 2024

Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing™ to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata

May 31, 2024

Quantum-Si Announces Presentations at ASMS and ESHG

May 30, 2024

Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors

May 9, 2024

Quantum-Si Reports First Quarter 2024 Financial Results

April 30, 2024

Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time

April 18, 2024

Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024

March 21, 2024

Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors

March 7, 2024

Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference

February 29, 2024

Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results

February 27, 2024

Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar

February 9, 2024

Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024

February 5, 2024

Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform

January 18, 2024

Quantum-Si Introduces World’s First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor

December 12, 2023

Quantum-Si Expands Global Reach with Addition of New Distributor

November 15, 2023

Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows

November 9, 2023

Quantum-Si Reports Third Quarter 2023 Financial Results

November 8, 2023

Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards

November 1, 2023

Quantum-Si to Participate at Two Upcoming Investor Conferences

October 31, 2023

Quantum-Si Presents its Vision to Transform Genomics and Proteomics Research at ASHG 2023

October 17, 2023

Quantum-Si to Report Third Quarter 2023 Financial Results on November 9, 2023

October 5, 2023

Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization

October 3, 2023

Quantum-Si to Present at The Festival of Genomics & Biodata 2023 in Boston, Massachusetts

September 21, 2023

Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors

August 22, 2023

Quantum-Si’s Platinum™ Next-Generation Protein Sequencing Instrument Wins Honorable Mention in Fast Company’s 2023 Innovation by Design Awards

August 16, 2023

Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 14, 2023

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 7, 2023

Quantum-Si Reports Second Quarter 2023 Financial Results

July 26, 2023

Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference

July 18, 2023

Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023

June 21, 2023

Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations

June 7, 2023

Quantum-Si Debuts New Headquarters in Branford, Connecticut

May 25, 2023

Quantum-Si to Participate in the Jefferies Healthcare Conference

May 22, 2023

Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors

May 15, 2023

Scott Mendel Elected to Quantum-Si Board of Directors

May 11, 2023

Quantum-Si Reports First Quarter 2023 Financial Results

May 2, 2023

Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer

April 24, 2023

Quantum-Si Bolsters Executive Leadership Team with Four Key Appointments

April 20, 2023

Quantum-Si to Report First Quarter 2023 Financial Results on May 11, 2023

April 14, 2023

Quantum-Si To Present Poster on Single-Molecule Method for Detection of Arginine Post-Translational Modifications at the AACR Annual Meeting 2023

March 24, 2023

Quantum-Si to Participate in B. Riley Securities’ Life Sciences Tools Conference – Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference

March 6, 2023

Quantum-Si Reports Fourth Quarter and Fiscal Year 2022 Financial Results

February 17, 2023

Quantum-Si to Participate in the 43rd Annual Cowen Health Care Conference

February 13, 2023

Quantum-Si to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

January 9, 2023

Quantum-Si and Aviva Systems Biology Partner to Co-Develop Sample Preparation Kits for Protein Sequencing

January 9, 2023

Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum™ Next-Generation Protein Sequence Platform Output

January 9, 2023

Quantum-Si Begins Commercial Shipments of the PlatinumTM Protein Sequencing System and Provides Business Updates at the 41st Annual J.P. Morgan Healthcare Conference

December 22, 2022

Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference

December 20, 2022

Quantum-Si Announces Commercial Availability of PlatinumTM, the World’s First Next-Generation Single-Molecule Protein Sequencing Platform

December 8, 2022

Quantum-Si Joins Human Proteome Organization (HUPO) Industrial Advisory Board

November 7, 2022

Quantum-Si Reports Third Quarter 2022 Financial Results

November 3, 2022

Quantum-Si to Participate in the 16th Annual Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

October 17, 2022

Quantum-Si to Report Third Quarter 2022 Financial Results on November 7, 2022

October 13, 2022

Quantum-Si’s Next-Generation Single-Molecule Protein Sequencing Technology Published in Science, Signaling New Era of Life Science and Biomedical Research

October 4, 2022

Quantum-Si Appoints Jeff Hawkins as Chief Executive Officer

August 26, 2022

Quantum-Si to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

August 8, 2022

Quantum-Si Reports Second Quarter 2022 Financial Results

July 29, 2022

Quantum-Si to Participate at Two Upcoming Investor Conferences

July 18, 2022

Quantum-Si to Report Second Quarter 2022 Financial Results on August 8, 2022

June 22, 2022

Quantum-Si Set to Join the Russell 2000® Index

June 16, 2022

Quantum-Si Appoints Vikram Bajaj, Ph.D., to Board of Directors

June 1, 2022

Quantum-Si Highlights Technology Advancements at the VIB Next-Generation Protein Analysis and Detection Conference

May 25, 2022

Quantum-Si to Present at the 2022 Jefferies Healthcare Conference

May 17, 2022

Quantum-Si to Present Research and Development Updates at the VIB Next-Generation Protein Analysis and Detection Conference

May 10, 2022

Quantum-Si to Present at the 2022 UBS Global Healthcare Conference

May 9, 2022

Quantum-Si Reports First Quarter 2022 Financial Results

May 9, 2022

Quantum-Si Appoints Patrick Schneider as President and Chief Operating Officer

April 18, 2022

Quantum-Si to Report First Quarter 2022 Financial Results on May 9, 2022

March 28, 2022

Quantum-Si to Present at the B. Riley Securities’ Disruptive Biotech Enabling Technologies Virtual Mini Conference

February 28, 2022

Quantum-Si Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 18, 2022

Quantum-Si to Present at the 42nd Annual Cowen Health Care Conference

February 14, 2022

Quantum-Si Announces Dr. Jonathan Rothberg as Interim CEO

February 7, 2022

Quantum-Si to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

January 10, 2022

Quantum-Si Provides Business Updates at the 40th Annual J.P. Morgan Healthcare Conference

January 4, 2022

Quantum-Si Signs Lease for New Headquarters in New Haven

December 21, 2021

Quantum-Si to Present at the 40th Annual J.P. Morgan Healthcare Conference

December 14, 2021

Quantum-Si Added to the Nasdaq Biotechnology Index

November 10, 2021

Quantum-Si Reports Third Quarter 2021 Financial Results

November 9, 2021

Quantum-Si Acquires Majelac Technologies to Strengthen Chip Supply Chain

November 4, 2021

Quantum-Si to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

October 21, 2021

Quantum-Si to Report Third Quarter 2021 Financial Results on November 11, 2021

October 19, 2021

Quantum-Si Announces Expansion of Early Access Program for the Platinum™ Single Molecule Protein Sequencing Platform

September 21, 2021

Quantum-Si Incorporated to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

August 16, 2021

Quantum-Si Reports Second Quarter 2021 Financial Results

August 11, 2021

Quantum-Si to Report Second Quarter 2021 Financial Results on August 16, 2021

July 27, 2021

Quantum-Si to Report Second Quarter 2021 Financial Results on August 12, 2021

June 24, 2021

Quantum-Si Signs Lease for Product Development and Operations Facility in San Diego Biotechnology Hub

June 10, 2021

Quantum-Si, Revolutionizing Proteomics, Closes Business Combination and Will Begin Trading Under the Ticker “QSI” on the Nasdaq Stock Exchange

May 17, 2021

Quantum-Si and HighCape Capital Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination

May 6, 2021

Quantum-Si Strengthens Board of Directors with Two Key Appointments

April 29, 2021

Quantum-Si Appoints Dr. Michael Mina as Chief Medical Advisor

April 23, 2021

Quantum-Si Announces Appointment of Claudia Napal Drayton as Chief Financial Officer

February 18, 2021

Quantum-Si, a Pioneer in Semiconductor Chip-Based Proteomics, to Combine with HighCape Capital Acquisition Corp.